Renovaro (RENB) News Today → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free RENB Stock Alerts $0.95 -0.09 (-8.68%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 7:32 PM | washingtonpost.comRenovaro: Fiscal Q3 Earnings SnapshotApril 30, 2024 | globenewswire.comTransforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on FragmentomicsApril 24, 2024 | globenewswire.comRenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics PartnershipApril 20, 2024 | uk.investing.comRenovaro appoints distinguished professor as new Chair of Scientific BoardApril 18, 2024 | finance.yahoo.comRenovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient CareMarch 15, 2024 | marketbeat.comRenovaro Inc. (NASDAQ:RENB) Sees Large Decline in Short InterestRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the target of a large decline in short interest in February. As of February 29th, there was short interest totalling 825,900 shares, a decline of 24.9% from the February 14th total of 1,100,000 shares. Based on an average daily volume of 195,900 shares, the short-interest ratio is currently 4.2 days. Currently, 1.5% of the company's stock are short sold.March 12, 2024 | markets.businessinsider.comONGOING INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBMarch 10, 2024 | markets.businessinsider.comINVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 28, 2024 | stockhouse.comRenovaro Shareholder NoticeFebruary 26, 2024 | stockhouse.comRenovaro Shareholder AlertFebruary 25, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 23, 2024 | finance.yahoo.comRENB Apr 2024 2.500 callFebruary 22, 2024 | investorplace.comRed Flag Alert: 3 Stocks That Hindenburg Research Is Shorting NowFebruary 18, 2024 | markets.businessinsider.comRenovaro Ongoing Investor AlertFebruary 17, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 16, 2024 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 15, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 15, 2024 | globenewswire.comCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplaceFebruary 14, 2024 | sg.finance.yahoo.comHit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion PieceFebruary 14, 2024 | msn.comRenovaro Biosciences soars after responding to Hindenburg short callFebruary 14, 2024 | finanznachrichten.deRenovaro Biosciences Inc.: Statement of Renovaro IncFebruary 14, 2024 | finance.yahoo.comStatement of Renovaro IncFebruary 14, 2024 | globenewswire.comStatement of Renovaro IncFebruary 14, 2024 | stockhouse.comRenovaro Investor AlertFebruary 13, 2024 | tmcnet.comROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 13, 2024 | finance.yahoo.comCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplaceFebruary 13, 2024 | businesswire.comROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENBFebruary 13, 2024 | marketbeat.comTrading was temporarily halted for "RENB" at 09:02 AM with a stated reason of "LULD pause."February 13, 2024 | marketbeat.comTrading was temporarily halted for "RENB" at 09:02 AM with a stated reason of "LULD pause."February 8, 2024 | msn.comRenovaro Biosciences Expands Share Capital SignificantlyJanuary 26, 2024 | msn.comRenovaro Biosciences Announces Final Meeting Vote ResultsJanuary 25, 2024 | finanznachrichten.deRenovaro Biosciences Inc.: Renovaro Biosciences Announces Results of Special Meeting of ShareholdersJanuary 25, 2024 | finance.yahoo.comRenovaro Biosciences Announces Results of Special Meeting of ShareholdersJanuary 18, 2024 | finance.yahoo.comRenovaro BioSciences Releases CEO Shareholder MessageJanuary 17, 2024 | theglobeandmail.comRenovaro BioSciences (NASDAQ: RENB) Releases CEO Shareholder MessageJanuary 16, 2024 | tmcnet.comMessage from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MDJanuary 16, 2024 | finance.yahoo.comMessage from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MDJanuary 11, 2024 | stockhouse.comSHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates RENB, HA, AYXDecember 1, 2023 | finance.yahoo.comRenovaro BioSciences CEO Featured in Recent Proactive InterviewNovember 23, 2023 | finance.yahoo.comRenovaro BioSciences Poised to Spearhead Advancements in Battle Against DiseasesNovember 22, 2023 | finance.yahoo.comRenovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024November 21, 2023 | finance.yahoo.comRenovaro BioSciences Eyes Opportunity in Precision Medicine MarketNovember 16, 2023 | marketbeat.comUnlocking AI investment opportunities in healthcare (RENB)AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.November 14, 2023 | finance.yahoo.comRenovaro Biosciences CEO Provides Update on Combination with GEDiCubeNovember 10, 2023 | finance.yahoo.comRenovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, BiotherapeuticsNovember 8, 2023 | morningstar.comRenovaro Biosciences Inc RENBNovember 7, 2023 | finance.yahoo.comRenovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company RENB Media Mentions By Week RENB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼1.890.55▲Average Medical News Sentiment RENB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼21▲RENB Articles Average Week Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Omeros News Ovid Therapeutics News Rigel Pharmaceuticals News Galectin Therapeutics News Atossa Therapeutics News Emergent BioSolutions News Merrimack Pharmaceuticals News Trevi Therapeutics News Design Therapeutics News Generation Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
